|
DRAM2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.589790E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.666400E-01 |
| Normal-vs-Stage2 |
8.046400E-02 |
| Normal-vs-Stage3 |
1.899770E-01 |
| Normal-vs-Stage4 |
7.647000E-01 |
| Stage1-vs-Stage2 |
2.840200E-01 |
| Stage1-vs-Stage3 |
6.755400E-01 |
| Stage1-vs-Stage4 |
5.220600E-01 |
| Stage2-vs-Stage3 |
5.822400E-01 |
| Stage2-vs-Stage4 |
2.353200E-01 |
| Stage3-vs-Stage4 |
4.485000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.878400E-02 |
| Normal-vs-AfricanAmerican |
6.459800E-01 |
| Normal-vs-Asian |
9.542600E-01 |
| Caucasian-vs-AfricanAmerican |
7.818800E-01 |
| Caucasian-vs-Asian |
1.439590E-01 |
| AfricanAmerican-vs-Asian |
6.633400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.858000E-01 |
| Normal-vs-Female |
1.177230E-01 |
| Male-vs-Female |
1.385830E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.737200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.136010E-01 |
| Normal-vs-Age(61-80Yrs) |
7.941400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.723200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.799600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.329600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.314000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.948000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.080400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.158400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.772800E-01 |
| Classical-VS-Follicular |
6.952400E-01 |
| Classical-VS-Other |
8.498400E-01 |
| Classical-VS-Normal |
2.996000E-01 |
| Tall-VS-Follicular |
5.027200E-01 |
| Tall-VS-Other |
6.518200E-01 |
| Tall-VS-Normal |
1.913970E-01 |
| Follicular-VS-Other |
9.752600E-01 |
| Follicular-VS-Normal |
5.695000E-01 |
| Other-VS-Normal |
7.999800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.807800E-02 |
| Normal-vs-N1 |
1.145790E-01 |
| N0-vs-N1 |
8.965200E-01 |
|
|
